推薦產(chǎn)品
3-(4-chlorophenyl)-4-phenyl-4,5-dihydro-1H-pyrazole 2-(chloromethyl)-3-methylpyridinehydrochloride 1-(2-bromo-4-methylphenyl)ethanone 3-chloroisoquinoline-4-carbonitrile 5,8-dichloropyrido[3,2-d]pyridazine 2-bromomalononitrile 2-(4-(bromomethyl)phenyl)benzo[d]thiazole 1-(bromomethyl)-3-methoxy-2-nitrobenzene 6-bromo-1H-[1,2,3]triazolo[4,5-b]pyridine 4-iodo-2-((trimethylsilyloxy)methyl)thiazole 6-iodoimidazo[1,2-a]pyridine-3-carbonitrile 2-(4-chlorophenyl)-2-morpholinoacetonitrile 4-chloro-7H-pyrrolo[2,3-d]pyrimidine 4-chloroisothiazole 5-bromo-6-chloro-1H-indole 7-chloro-3H-imidazo[4,5-b]pyridine ethyl3-(4-formylphenyl)propanoate 2,3-dibromobenzaldehyde 1-(5H-chromeno[2,3-b]pyridin-7-yl)ethanone 5H-chromeno[2,3-b]pyridin-5-one 3-chloroisoquinoline-4-carbaldehyde (E)-2-(3-oxoprop-1-enyl)benzaldehyde methyl4-formyl-3-nitrobenzoate 5,6-dimethoxy-2,2-dimethyl-2,3-dihydro-1H-inden-1-one 1-methylbicyclo[4.1.0]heptan-3-one 3-nitro-4-(trifluoromethoxy)benzaldehyde 2-hydroxyquinoline-6-carbaldehyde 2-nitro-3-(trifluoromethyl)benzaldehyde 1-(2-fluoro-4-methoxyphenyl)propan-2-one tert-butyl3-fluoro-4-oxopiperidine-1-carboxylate tert-butyl3-oxopropylcarbamate 2,2-dimethylcyclohexanone 9H-carbazole-3-carbaldehyde N,N-dimethyl-2-oxoacetamide 2-methylpent-4-yn-2-ol 3-tert-butyl-4-hydroxybenzonitrile 4-bromo-2-tert-butylphenol 1,3-dibutoxypropan-2-ol methyl4-hydroxyquinoline-6-carboxylate methyl3-cyano-4-hydroxybenzoate 4-chloro-6-methoxyquinolin-7-ol 3,4-dihydro-2H-benzo[b][1,4]oxazin-7-ol 2-(2-aminothiazol-5-yl)ethanolhydrochloride (R)-ethyl2-chloropropanoate (S)-4-amino-5-(4,4-dimethylcyclohexylamino)-5-oxopentanoicacid (1s,4s)-4-hydroxycyclohexanecarboxylicacid (S)-2-(tetrahydrofuran-3-yloxy)aceticacid (1S,4R)-1-methyl-4-(prop-1-en-2-yl)cyclohex-2-enol (R)-4-(hydroxymethyl)oxazolidin-2-one (S)-4-(hydroxymethyl)oxazolidin-2-one 化工資訊 正值傳統(tǒng)淡季，加上歐洲人多在夏季休假，上周國際鉀肥市場持續(xù)平靜，中國和印度也沒有新的合同成交。但在沉靜的表面之下，市場信心在逐漸增加，畢竟大合同的確定已為市場提供了基準(zhǔn)價格，供應(yīng)商也對此充滿期待。
加鉀公司宣稱國際鉀肥市場已經(jīng)到底，Intrepid和美盛公司也附和了這一觀點，認(rèn)為鉀肥價格將從下半年開始觸底反彈。
對生產(chǎn)企業(yè)來說這些都是利好消息。不久前中國確認(rèn)了第一批氯化鉀大合同，印度則是在6月底，合同到岸價分別確定在219美元和227美元。巴西和美國市場氯化鉀價格已經(jīng)回升，同時有跡象表明全球范圍內(nèi)氯化鉀價格都趨于穩(wěn)定，買家也陸續(xù)對市場重拾興趣。
市場究竟如何發(fā)展還有待觀察。有觀點認(rèn)為供應(yīng)商獲得了短期內(nèi)議價的主動權(quán)，畢竟中國和印度8、9月份的合同訂單已占據(jù)了他們大部分的產(chǎn)量，也減輕了他們的銷售壓力，供應(yīng)其他市場的數(shù)量有限。
一部分買家將等待價格泡沫破滅，而另外一部分買家則會瞄準(zhǔn)時機(jī)適時出手。
